Petraitis V, Petraitiene R, Katragkou A, Maung BBW, et al. Combination Therapy with Ibrexafungerp (formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1-->3)-beta-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother 2020 Mar 16. pii: AAC.02429.
PMID: 32179521